期刊文献+

醋酸钙联合高通量低钙透析治疗尿毒症患者高磷血症的临床效果 被引量:5

Clinical Effect of Calcium Acetate Combined with High-flux Low-calcium Dialysis in Treatment of Hyperphosphatemia in Uremia Patients
下载PDF
导出
摘要 目的研究醋酸钙联合高通量低钙透析治疗尿毒症患者高磷血症对血钙及血磷水平的影响及临床效果。方法 2013年7月-2015年6月期间,将我院收治的126例尿毒症患者根据入院单双日均分为对照组和实验组,每组63例。两组患者均给予血液透析治疗,对照组口服碳酸钙片剂,每次1片,每天3次;实验组口服醋酸钙,每次2片,每天3次。比较两组患者治疗前后血钙、血磷、全段甲状旁腺激素水平的统计差异。结果两组患者治疗后30天和60天,血红蛋白、血浆白蛋白、钙磷乘积、矫正血钙、碱性磷酸酶含量的差异均有统计学意义(P<0.05);两组患者血磷、血钙、i PTH含量比较,差异有统计学意义(P<0.05);两组患者治疗有效率的差异有统计学意义(2=22.676,P=0.00);两组患者感染发生情况、副反应疗效、患者自我体检比较,其差异均有统计学意义(P<0.05)。结论醋酸钙联合高通量低钙透析治疗尿毒症有助于稳定患者的血钙水平,且降低血磷和i PTH水平,不良反应少,对于预防高磷血症以及心血管并发症具有积极意义。 Objective To Investigate the effect of calcium acetate combined with high-flux and low-calcium dialysis on blood calcium and phosphorus levels in hyperphosphatemia in uremic patients and clinical efficacy. Methods From July 2013 to June 2015,126 patients with uremia admitted to our hospital were divided into control group and experimental group according to admissions and double days,with 63 cases in each group. Both groups were given hemodialysis treatment. The control group received oral calcium carbonate tablets one tablet at a time and 3 times a day. The experimental group received oral calcium acetate,two tablets at a time,and three times daily. The statistical differences in blood calcium,phosphorus,and parathyroid hormone levels before and after treatment were compared between the two groups. Results The differences in hemoglobin,plasma albumin,calcium and phosphorus,calcium and alkaline phosphatase contents were statistically significant( P〈0. 05) after treatment for 30 days and 60 days after treatment. In the two groups,there was a statistically significant difference in blood phosphorus,blood calcium and i PTH content( P〈0. 05). The difference in treatment efficiency between the two groups was statistically significant( x^2= 22. 676,P = 0. 00). There were statistically significant differences in the incidence of infection,side effects,and patient self-examinations between the two groups( P〈0. 05). Conclusions Calcium acetate joint high flux of low calcium dialysis in patients with uremia help stabilize blood calcium levels,and reduce the blood level of phosphorus and i PTH,less adverse reaction,to prevent hyperphosphatemia and cardiovascular complications has positive significance.
作者 黄辉传 张建军 吕伟权 陈玉秀 HUANG Huichuan;ZHANG Jianjun;LV Weiquan;CHEN Yuxiu
机构地区 惠东县人民医院
出处 《现代医院》 2018年第4期565-568,共4页 Modern Hospitals
关键词 醋酸钙 高通量低钙 透析治疗 尿毒症 Calcium Acetate High-Throughput Low-Calcium Dialysis Uremia
  • 相关文献

参考文献13

二级参考文献98

  • 1陆文进,张凌.低钙透析液用于血液透析的临床观察[J].中国血液净化,2004,3(8):410-412. 被引量:9
  • 2孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 3陈朝生,徐玉兰,梅晓蓉,许菲菲,郑尘非,刘毅,王绿萍,黄朝兴.高通量血透对血浆同型半胱氨酸和超敏C反应蛋白的影响[J].中华肾脏病杂志,2006,22(8):506-507. 被引量:16
  • 4Goodman WG. Coronary-ariery calcification in young aduhs with end-stage remal disease who are undergoing dialysis[J]. The new England jourmal of medicine,2000,342 ( 20 ): 1478-1483.
  • 5Janssen MJA, Vanderkuy A, terwee PM, et al.Aluminum hydro colcium carbonate and calcium acetate in chronic interillinent hemodialysis patients[J]. Cliniealneplvology, 1996,45: 111.
  • 6Nappi SE, Virtanen VK, Saha HHT, et al.QTc dispersion be increase duing he modialysis with low eacium dialystatc[J].Kidney Lnt, 2000,57:2117-2122.
  • 7苗华,潘明明.慢性肾衰竭高磷血症研究及治疗进展[J].中国血液净化,2007,6(9):500-502. 被引量:24
  • 8Keith AH,Suresh M,Richard L,et al.Hyperphosphatemia of Chronic Kidney Disease[J].Kidney Int,2008,74(2);148-157.
  • 9Keith A.Hruska,Suresh M.The Roles of the Skeleton and Phos- phorus in the CKD Mineral Bone Disorder[J].Adv Chronic Kidney Dis,2011,18(2):98-104.
  • 10Veerle PP,Geert JB,Marc ED,et al.Management of hyperphos- phatemia in patients with end-stage renal disease:focus on lan- thanum carbonate[J].Int J Nephrol Renovasc Dis,2009(2):1-8.

共引文献68

同被引文献34

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部